Athira Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-117.67	-95.64	-54.85	-19.96	-5.16	-5.1
Depreciation & Amortization	1.18	1.05	0.63	0	0	0
Share-Based Compensation	10.62	10.61	4.62	0.63	0.25	0.2
Other Operating Activities	5.11	11.52	6.5	-4.79	1.2	0.42
Operating Cash Flow	-100.75	-72.47	-43.1	-24.11	-3.71	-4.48
Capital Expenditures	-0.3	-1.14	-1.57	-2.32	0	0
Acquisitions	0	0	0	0.04	0.01	0.01
Change in Investments	95.39	58.81	-2.51	-207.78	1.5	2
Investing Cash Flow	95.09	57.66	-4.08	-210.07	1.51	2.01
Share Issuance / Repurchase	0.49	0.65	97.09	209.16	0.07	0.11
Debt Issued / Paid	0	0	0	1.66	0.87	1.25
Other Financing Activities	-	-	-	81.93	-	0.1
Financing Cash Flow	0.49	0.65	97.09	292.75	0.95	1.46
Net Cash Flow	-5.17	-14.15	49.91	58.57	-1.26	-1.01
Free Cash Flow	-101.06	-73.61	-44.67	-26.43	-3.71	-4.48
Free Cash Flow Per Share	-2.66	-1.95	-1.21	-2.21	-1.04	-1.29

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).